Abstract
Three classes of drugs were found, after their i.p. administration, to inhibit Paf-acether-induced edema of the rat's paw. These were beta-adrenergic agonists (isoproterenol, salbutamol), alpha-adrenergic antagonists (prazosin, ergotamine, yohimbine, phenoxybenzamine), and calcium entry blockers (nifedipine, verapamil, diltiazem). A number of other drugs including steroidal and nonsteroidal antiinflammatory agents, alpha-agonists, beta-antagonists, pyrilamine, atropine, methysergide, a lipoxygenase inhibitor, and a leukotriene antagonist did not inhibit the development of the edema. Propranolol, but not practolol, antagonized the inhibitory effect of isoproterenol which provided evidence for involvement of beta-2 receptors in the mechanism of action of the beta agonists. It is suggested that cellular calcium influx is involved in the edemagenic response observed after the injection of Paf-acether into the rat's paw.
Similar content being viewed by others
References
B.B. Vargaftig, M. Chignard, J. Benveniste, J. Lefort andF. Wal,Background and present status of research on platelet activating factor (Paf-acether), Ann. N.Y. Acad. Sci.37, 119–137 (1981).
C.P. Page, W. Paul andJ. Morley,Platelets and bronchospasm, Int. Archs. Allergy appl. Immunol.74, 347–350 (1984).
S.R. Findlay, L.M. Lichtenstein, D.J. Hanahan andR.N. Pinckard,The contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine, Am. J. Physiol.241, C130 (1981).
D.M. Humphrey, D.J. Hanahan andR.N. Pinckard,Induction of leukocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine, Lab. Invest.47, 227–234 (1982).
M. Sanchez-Crespo, F. Alonso, P. Inarrea, V. Alvarez andJ. Egido,Vascular actions of synthetic Paf-acether (a synthetic platelet activating factor) in the rat: evidence for a platelet independent mechanism, Immunopharmacology4, 173–185 (1982).
D.M. Humphrey, L.M. McManus, K. Satouchi, D.J. Hanahan andR.N. Pinckard,Vasoactive properties of acetyl glyceryl phosphorylcholine and analogues, Lab. Invest.46, 422–427 (1982).
R. Patterson andK.E. Harris,The activity of aerosolized and intracutaneous synthetic platelet activating factor (AGEPC) in rhesus monkeys with IgE-mediated airway responses and normal monkeys, J. Lab. Clin. Med.102, 933–938 (1983).
A. Denjean, B. Arnaux, J. Benveniste, A. Lockhart andR. Masse,Bronchoconstriction induced by intratracheal administration of platelet activating factor (Paf-acether) in baboons, Agents Actions11, 567–568 (1981).
L.M. McManus, D.J. Hanahan, C.A. Demopoulos andR.N. Pinckard,Pathobiology of acetyl glyceryl ether phosphorocholine (AGEPC), a synthetic platelet activating factor (PAF), in the rabbit, J. Immunol.124, 2919–2924 (1980).
R.N. Pinckard, W.T. Kniker, L. Lee, D.J. Hanahan andL.M. McManus,Vasoactive effects of 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AcGEPC) in human skin, J. Allergy Clin. Immunol.65, 196 (1980).
J. Bonnet, A.M. Loiseau, M. Orvoen andP. Bessin,Platelet activating factor acether (Paf-acether) involvement in acute inflammatory and pain processes, Agents Actions11, 559–562 (1981).
M.M. Goldenberg andR.D. Meurer,A pharmacological analysis of the action of platelet activating factor in the induction of hindpaw edema in the rat, Prostaglandins28, 271–178 (1984).
B.B. Vargaftig andS.H. Ferreira,Blockade of the inflammatory effects of platelet-activating factor by cyclooxygenase inhibitors, Brazilian J. Med. Biol. Res.14, 187–189 (1981).
T.F. Blaschke andK.L. Melmon, Antihypertensive agents and the drug therapy of hypertension. InThe Pharmacological Basis of Therapeutics, 6th edition,A.G. Gilman, L.S. Goodman, A. Gilman, eds, Macmillan, N.Y., p. 797 (1980).
P.A. Van Zwieten andP.B.M.W.M. Timmermans,Central and peripheral alpha-adrenoceptors. Pharmacological aspects and clinical potential, Adv. Drug Res.13, 209–254 (1984).
K.E. Kamm andJ.T. Stull,The function of myosin and myosin light chain kinase phosphorylation in smooth muscle, Annu. Rev. Pharmacol. Toxicol.25, 593–620 (1985).
L.J. Ignarro andP.J. Kadowitz,The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu. Rev. Pharmacol. Toxicol.25, 171–191 (1985).
K.F. Swingle, L.W. Jaques andD.C. Kvam,Differences in the severity of adjuvant arthritis in four strains of rats, Proc. Soc. Exp. Biol. Med.132, 608–612 (1969).
D.M. Humphrey, L.M. McManus, K. Satouchi, D.J. Hanahan andR.N. Pinckard,Vasoactive properties of acetyl glyceryl ether phosphoroylcholine and analogues, Lab. Invest.46, 422–427 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Swingle, K.F., Reiter, M.J. Inhibition of Paf-acether-induced Edema of the Rat's Paw. Agents and Actions 18, 359–365 (1986). https://doi.org/10.1007/BF01964997
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01964997